161 related articles for article (PubMed ID: 1708056)
1. Effects of pirmenol on electrical induction of sustained ventricular tachycardia in a seven-day-old canine myocardial infarction.
Nitta J; Nogami A; Aonuma K; Akimoto H; Chung YH; Takahashi A; Iesaka Y; Marumo F; Hiraoka M
J Cardiovasc Pharmacol; 1991 Jan; 17(1):54-60. PubMed ID: 1708056
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiologic actions of pirmenol in dogs with recent myocardial infarction.
Lynch JJ; DiCarlo LA; Montgomery DG; Hassan T; Lucchesi BR
Am Heart J; 1986 Oct; 112(4):752-8. PubMed ID: 3766375
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery disease.
Easley AR; Mann DE; Reiter MJ; Sakun V; Sullivan SM; Magro SA; Luck JC; Wyndham CR
Am J Cardiol; 1986 Jul; 58(1):86-9. PubMed ID: 3728337
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic effects of E-4031, a class III antiarrhythmic agent, on re-entrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model.
Katoh H; Ogawa S; Furuno I; Sato Y; Yoh S; Saeki K; Nakamura Y
J Pharmacol Exp Ther; 1990 Jun; 253(3):1077-82. PubMed ID: 2359016
[TBL] [Abstract][Full Text] [Related]
5. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.
Gold RL; Frumin H; Haffajee CI; Kerin NZ; Jarandilla R
Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418
[TBL] [Abstract][Full Text] [Related]
6. Iontophoretic transmyocardial drug delivery. A novel approach to antiarrhythmic drug therapy.
Avitall B; Hare J; Zander G; Bockoff C; Tchou P; Jazayeri M; Akhtar M
Circulation; 1992 Apr; 85(4):1582-93. PubMed ID: 1555296
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia.
Miura DS; Schwartz J; Laux B; Wynn J; Keefe D; Somberg JC
J Clin Pharmacol; 1987 Jul; 27(7):481-6. PubMed ID: 3654999
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic efficacy of a new class III agent, UK-68,798, during chronic myocardial infarction: evaluation using three-dimensional mapping.
Zuanetti G; Corr PB
J Pharmacol Exp Ther; 1991 Jan; 256(1):325-34. PubMed ID: 1988663
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiology and antiarrhythmic efficacy of intravenous pirmenol in patients with sustained ventricular tachyarrhythmias.
Liem LB; Clay DA; Franz MR; Swerdlow CD
Am Heart J; 1987 Jun; 113(6):1390-6. PubMed ID: 3591608
[TBL] [Abstract][Full Text] [Related]
10. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
Kus T; Costi P; Dubuc M; Shenasa M
Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
[TBL] [Abstract][Full Text] [Related]
11. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug.
Black SC; Butterfield JL; Lucchesi BR
J Cardiovasc Pharmacol; 1993 Dec; 22(6):810-8. PubMed ID: 7509898
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of pirmenol and lidocaine on intraventricular conduction in canine myocardial infarction.
Hashimoto H; Ozaki T; Nagashima S; Nakashima M
J Electrocardiol; 1991 Oct; 24(4):379-85. PubMed ID: 1744550
[TBL] [Abstract][Full Text] [Related]
13. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN
Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide.
Karagueuzian HS; Sugi K; Ohta M; Meesmann M; Ino T; Peter T; Mandel WJ
Am Heart J; 1986 Dec; 112(6):1173-83. PubMed ID: 3788764
[TBL] [Abstract][Full Text] [Related]
15. Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction.
Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Selnick HG; Stein RB
J Cardiovasc Pharmacol; 1990 May; 15(5):764-75. PubMed ID: 1692937
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic effects of bepridil in normal and infarcted canine myocardium.
Lynch JJ; DiCarlo LA; Montgomery DG; Lucchesi BR
J Cardiovasc Pharmacol; 1986; 8(5):957-66. PubMed ID: 2429097
[TBL] [Abstract][Full Text] [Related]
17. Late potentials on the signal-averaged electrocardiogram after canine myocardial infarction: correlation with induced ventricular arrhythmias during the healing phase.
Kuchar DL; Rosenbaum DS; Ruskin J; Garan H
J Am Coll Cardiol; 1990 May; 15(6):1365-73. PubMed ID: 2329240
[TBL] [Abstract][Full Text] [Related]
18. Discordant prolongation of the refractory period and repolarization time by a class III agent, E4031, in the healing phase of myocardial infarction.
Takatsuki S; Mitamura H; Sueyoshi K; Kanki H; Furuno I; Ogawa S
Jpn Heart J; 1998 Sep; 39(5):687-97. PubMed ID: 9926000
[TBL] [Abstract][Full Text] [Related]
19. Promotion of ventricular tachycardia induction by procainamide in dogs with inducible ventricular fibrillation late after myocardial infarction.
Hunt GB; Ross DL
Pacing Clin Electrophysiol; 1990 Jul; 13(7):882-9. PubMed ID: 1695745
[TBL] [Abstract][Full Text] [Related]
20. Effects of procainamide and lidocaine on electrically inducible ventricular tachycardia studied with programmed ventricular stimulation in post myocardial infarction.
Iesaka Y; Aonuma K; Nitta J; Tokunaga T; Fujiwara H; Hiraoka M
Jpn Circ J; 1988 Mar; 52(3):262-71. PubMed ID: 3373718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
